Therapeutic Drug Concentration Monitoring Using Saliva SamplesFocus on Anticonvulsants

被引：0
作者：
Hua Liu
Mauricio R. Delgado
机构：
[1] Texas Scottish Rite Hospital for Children,Department of Research
[2] Texas Scottish Rite Hospital for Children,Department of Neurology
来源：
Clinical Pharmacokinetics | 1999年 / 36卷
关键词：
High Performance Liquid Chromatography; Adis International Limited; Carbamazepine; Valproic Acid; Therapeutic Drug Monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the last 30 years there has been great interest in the use of saliva in therapeutic drug monitoring. Numerous investigators have suggested that saliva be used as an alternative body fluid for the therapeutic drug monitoring of anticonvulsant drugs. Not only can saliva be obtained easily on multiple occasions with minimal discomfort to the patient but, more importantly, useful relationships exist between the saliva and blood concentrations of the most commonly used anticonvulsant drugs.
引用
收藏
页码：453 / 470
页数：17
相关论文
共 283 条
[1]  
Mandel I.D.(1993)Salivary diagnosis: promises, promises Ann N Y Acad Sci 694 1-10
[2]  
McAuliffe J.J.(1977)Salivary levels of anticonvulsants: a practical approach to drug monitoring Neurology 27 409-13
[3]  
Sherwin A.L.(1977)Use of saliva in therapeutic drug monitoring Clin Chem 23 157-64
[4]  
Leppik I.E.(1978)Drug concentration in saliva Clin Pharmacol Ther 24 563-70
[5]  
Horning M.G.(1984)The place of saliva in antiepileptic drug monitoring Ther Drug Monit 6 35-41
[6]  
Brown L.(1990)Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy Epilepsy Res 6 146-54
[7]  
Nowlin J.(1992)Salivary excretion of drugs in children: theoretical and practical issues in therapeutic drug monitoring Dev Pharmacol Ther 19 161-77
[8]  
Mucklow J.C.(1992)Therapeutic drug monitoring in saliva: an update Clin Pharmacokinet 23 365-79
[9]  
Bending M.R.(1993)The role of saliva in drug monitoring Ann N Y Acad Sci 694 86-90
[10]  
Kahn G.C.(1997)Is saliva suitable for therapeutic monitoring of anticonvulsants in children: an evaluation in the routine clinical setting Ther Drug Monit 19 637-42
12345678910